More Young People Are Starting Addiction Treatment — Almost None Stay on Medication

Starting treatment and staying in treatment are not the same accomplishment, and this new data on young people with opioid use disorder makes that distinction impossible to ignore. More adolescents and young adults are reaching a clinician than before — but the study's sharpest finding is how few of them are still on medication six months later. A treatment system can open its doors wider and still lose almost everyone who walks through them.

That gap is where peer recovery support is built to do its work. Medication for opioid use disorder is only as effective as a young person's ability to stay connected to it — through the discomfort of early recovery, the disruptions of school or family life, and the stigma that still surrounds taking medication for a substance use disorder, especially for a teenager or young adult. A clinician can write a prescription; the drop-off this study describes suggests that a prescription alone isn't enough to keep someone engaged.

At The Zone, DDF's peer recovery support organization, that ongoing connection is the core of the work: certified peer recovery specialists who walk alongside people in recovery, including young adults, through the months after a first appointment, when engagement is most fragile. One of the study's authors points to a clinical environment that is appealing, safe, compassionate, and nonjudgmental as what actually keeps young people in care — a description that fits peer support as much as it fits any single treatment setting.

The study's finding on racial disparity also matters to how DDF thinks about its own community. Young Black people and other young people of color fell out of care at higher rates at nearly every stage studied, a reminder that access and retention gaps are not distributed evenly, and that outreach and support have to actively work against that pattern rather than assume a level playing field.

None of this diminishes how real the gains are: more young people are being diagnosed and starting treatment than in past years, and buprenorphine and methadone remain genuinely effective medications when people are able to stay on them. The work ahead, for clinicians and for community-based recovery support organizations alike, is making sure the system doesn't lose people after that first appointment. If you're a young person — or a parent of one — looking for support after a diagnosis or a first step into treatment, The Zone is here to help with what comes next.